Breaking News Instant updates and real-time market news.

CREE

Cree

$58.35 /

-3.97 (-6.37%)

07:20
09/22/20
09/22
07:20
09/22/20
07:20

Morgan Stanley says Cree poised to benefit from investments in EV, clean energy

Morgan Stanley analyst Craig Hettenbach notes that Cree shares have sold off 20% from a recent peak to a recent low after earnings, which he attributes to "a reality check that this is not an earnings inflection story but rather a multi-year growth opportunity." While he admits "there are going to be times when hype exceeds the near-term reality" for a stock levered to the theme of electric vehicle adoption, and that "this likely won't be the last 20% selloff," Hettenbach said investors should not "miss the forest for the trees" as he continues to see Cree as in a strong position to benefit from investments in EVs and clean energy that are "accelerating at breakneck speed." The analyst has an Overweight rating and $74 price target on Cree shares.

CREE Cree
$58.35 /

-3.97 (-6.37%)

09/04/20 Canaccord
Cree design wins add $1B market opportunity, says Canaccord
08/20/20 Citi
Cree price target lowered to $71 from $82 at Citi
08/19/20 Roth Capital
Cree downgraded to Neutral from Buy at Roth Capital
08/19/20 Wells Fargo
Cree price target raised to $65 from $45 at Wells Fargo

TODAY'S FREE FLY STORIES

Recommendations
Callaway acquisition brings larger customer base, says B. Riley Securities » 08:14
10/28/20
10/28
08:14
10/28/20
08:14
ELY

Callaway Golf

$19.27 /

-0.615 (-3.09%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELY Callaway Golf
$19.27 /

-0.615 (-3.09%)

ELY Callaway Golf
$19.27 /

-0.615 (-3.09%)

09/29/20 B. Riley FBR
Callaway Golf price target raised to $24 from $23 at B. Riley FBR
09/24/20 B. Riley FBR
B. Riley FBR highlights four apparel brands with little election risk
08/07/20 Compass Point
Callaway Golf downgraded to Neutral from Buy at Compass Point
07/22/20 B. Riley FBR
Callaway Golf price target raised to $21 from $16 at B. Riley FBR
ELY Callaway Golf
$19.27 /

-0.615 (-3.09%)

ELY Callaway Golf
$19.27 /

-0.615 (-3.09%)

ELY Callaway Golf
$19.27 /

-0.615 (-3.09%)

Hot Stocks
PURO Lighting announces strategic new alliance with Acuity Brands » 08:14
10/28/20
10/28
08:14
10/28/20
08:14
AYI

Acuity Brands

$91.79 /

+0.54 (+0.59%)

PURO UV Disinfection…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AYI Acuity Brands
$91.79 /

+0.54 (+0.59%)

AYI Acuity Brands
$91.79 /

+0.54 (+0.59%)

09/16/20 UBS
Acuity Brands initiated with a Sell at UBS
09/15/20 UBS
Acuity Brands initiated with a Sell at UBS
07/01/20 William Blair
William Blair says Acuity margins surprise, still cautious on sustainability
07/01/20 Roth Capital
Roth Capital says checks show Acuity Brands' number 1 customer lost
AYI Acuity Brands
$91.79 /

+0.54 (+0.59%)

AYI Acuity Brands
$91.79 /

+0.54 (+0.59%)

AYI Acuity Brands
$91.79 /

+0.54 (+0.59%)

Earnings
GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range » 08:14
10/28/20
10/28
08:14
10/28/20
08:14
GSK

GlaxoSmithKline

$35.37 /

+0.16 (+0.45%)

GSK said: "At…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
10/27/20 Wedbush
AnaptysBio upgraded to Outperform at Wedbush
10/15/20 SVB Leerink
SVB Leerink sees possible opportunity for Amarin to 'salvage Vascepa' in U.S.
10/12/20 UBS
GlaxoSmithKline price target lowered to 1,730 GBp from 1,800 GBp at UBS
GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

Recommendations
Avantor price target raised to $28 from $23 at Wells Fargo » 08:14
10/28/20
10/28
08:14
10/28/20
08:14
AVTR

Avantor

$24.43 /

-0.29 (-1.17%)

Wells Fargo analyst Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVTR Avantor
$24.43 /

-0.29 (-1.17%)

AVTR Avantor
$24.43 /

-0.29 (-1.17%)

10/09/20 Jefferies
Avantor price target raised to $30 from $25 at Jefferies
09/14/20 Morgan Stanley
Avantor initiated with an Overweight at Morgan Stanley
08/17/20
Loeb's Third Point buys Alibaba, makes a top holding, during second quarter
08/03/20 Truist
Avantor price target raised to $29 from $21 at Truist
AVTR Avantor
$24.43 /

-0.29 (-1.17%)

  • 20
    Aug
  • 21
    May
  • 08
    Jan
AVTR Avantor
$24.43 /

-0.29 (-1.17%)

Hot Stocks
ATIF Holdings signs $1M consulting service agreement with Lendmerit » 08:14
10/28/20
10/28
08:14
10/28/20
08:14
ATIF

ATIF Holdings

$1.19 /

+0.02 (+1.71%)

ATIF Holdings entered…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATIF ATIF Holdings
$1.19 /

+0.02 (+1.71%)

Earnings
Farmers National Banc reports Q3 EPS 38c, consensus 32c » 08:13
10/28/20
10/28
08:13
10/28/20
08:13
FMNB

Farmers National Banc

$11.51 /

-0.43 (-3.60%)

Reports Q3 book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMNB Farmers National Banc
$11.51 /

-0.43 (-3.60%)

FMNB Farmers National Banc
$11.51 /

-0.43 (-3.60%)

09/24/20 Boenning & Scattergood
Farmers National Banc resumed with an Outperform at Boenning & Scattergood
06/17/20 Raymond James
Farmers National Banc upgraded to Outperform from Market Perform at Raymond James
06/17/20 Raymond James
Farmers National Banc upgraded to Outperform from Market Perform at Raymond James
05/04/20 Raymond James
Farmers National Banc downgraded at Raymond James on valuation
FMNB Farmers National Banc
$11.51 /

-0.43 (-3.60%)

Hot Stocks
Boeing sees passenger traffic returning to 2019 levels in ~3 years » 08:13
10/28/20
10/28
08:13
10/28/20
08:13
BA

Boeing

$155.25 /

-5.61 (-3.49%)

Boeing sees a return to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$155.25 /

-5.61 (-3.49%)

BA Boeing
$155.25 /

-5.61 (-3.49%)

10/13/20 Wells Fargo
Hexcel price target lowered to $42 from $47 at Wells Fargo
10/07/20 Morgan Stanley
Boeing market outlook 'may still be optimistic,' says Morgan Stanley
10/06/20 Credit Suisse
Boeing price target raised to $184 from $154 at Credit Suisse
09/29/20 Morgan Stanley
Morgan Stanley stays Underweight on Boeing despite EASA news
BA Boeing
$155.25 /

-5.61 (-3.49%)

BA Boeing
$155.25 /

-5.61 (-3.49%)

BA Boeing
$155.25 /

-5.61 (-3.49%)

BA Boeing
$155.25 /

-5.61 (-3.49%)

Hot Stocks
Rhythm Pharmaceuticals appoints Jennifer Chien as EVP, head of North America » 08:13
10/28/20
10/28
08:13
10/28/20
08:13
RYTM

Rhythm Pharmaceuticals

$23.25 /

+0.47 (+2.06%)

, KRYS

Krystal Biotech

$48.59 /

+2.6 (+5.65%)

Rhythm Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RYTM Rhythm Pharmaceuticals
$23.25 /

+0.47 (+2.06%)

KRYS Krystal Biotech
$48.59 /

+2.6 (+5.65%)

RYTM Rhythm Pharmaceuticals
$23.25 /

+0.47 (+2.06%)

10/26/20 Stifel
Rhythm Pharmaceuticals price target raised to $36 from $31 at Stifel
01/08/20 Goldman Sachs
Rhythm Pharmaceuticals initiated with a Sell at Goldman Sachs
KRYS Krystal Biotech
$48.59 /

+2.6 (+5.65%)

09/18/20 B. Riley FBR
Krystal Biotech stared at Buy with 116% potential upside at B. Riley FBR
09/17/20 B. Riley FBR
Krystal Biotech initiated with a Buy at B. Riley FBR
08/19/20 Chardan
Chardan sees valuation upside through 2022 for Krystal Biotech
03/12/20 SMBC Nikko
Krystal Biotech initiated with an Outperform at SMBC Nikko
RYTM Rhythm Pharmaceuticals
$23.25 /

+0.47 (+2.06%)

KRYS Krystal Biotech
$48.59 /

+2.6 (+5.65%)

  • 19
    May
KRYS Krystal Biotech
$48.59 /

+2.6 (+5.65%)

Hot Stocks
ImStem obtains from AgeX a royalty-bearing sublicense for ESC line ESI-053 » 08:12
10/28/20
10/28
08:12
10/28/20
08:12
AGE

AgeX Therapeutics

$1.86 /

+0.235 (+14.46%)

AgeX Therapeutics and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGE AgeX Therapeutics
$1.86 /

+0.235 (+14.46%)

AGE AgeX Therapeutics
$1.86 /

+0.235 (+14.46%)

08/31/20 H.C. Wainwright
Lineage Cell extends cash runway to over two years, says H.C. Wainwright
Earnings
GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago » 08:12
10/28/20
10/28
08:12
10/28/20
08:12
GSK

GlaxoSmithKline

$35.37 /

+0.16 (+0.45%)

Reports Q3 revenue GBP…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
10/27/20 Wedbush
AnaptysBio upgraded to Outperform at Wedbush
10/15/20 SVB Leerink
SVB Leerink sees possible opportunity for Amarin to 'salvage Vascepa' in U.S.
10/12/20 UBS
GlaxoSmithKline price target lowered to 1,730 GBp from 1,800 GBp at UBS
GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

GSK GlaxoSmithKline
$35.37 /

+0.16 (+0.45%)

Hot Stocks
AerCap delivers new Airbus A321-200Neo to Sichuan Airlines » 08:12
10/28/20
10/28
08:12
10/28/20
08:12
AER

AerCap

$27.42 /

-1.39 (-4.82%)

, EADSY

Airbus

$0.00 /

+ (+0.00%)

AerCap (AER) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AER AerCap
$27.42 /

-1.39 (-4.82%)

EADSY Airbus
$0.00 /

+ (+0.00%)

AER AerCap
$27.42 /

-1.39 (-4.82%)

10/02/20 Deutsche Bank
Deutsche Bank opens 'short-term Buy Catalyst Call' on AerCap
06/01/20
Fly Intel: Top five analyst downgrades
06/01/20 BofA
AerCap downgraded to Neutral from Buy at BofA
05/27/20 Stephens
AerCap shouldn't need capital markets funding until 2021, says Stephens
EADSY Airbus
$0.00 /

+ (+0.00%)

10/14/20 Barclays
Airbus price target lowered to EUR 68 from EUR 71 at Barclays
10/13/20 JPMorgan
Airbus downgraded to Underweight from Neutral at JPMorgan
10/01/20 Berenberg
Airbus upgraded to Buy from Hold at Berenberg
09/17/20 Credit Suisse
Airbus price target raised to EUR 106 from EUR 78 at Credit Suisse
AER AerCap
$27.42 /

-1.39 (-4.82%)

EADSY Airbus
$0.00 /

+ (+0.00%)

  • 03
    Dec
AER AerCap
$27.42 /

-1.39 (-4.82%)

EADSY Airbus
$0.00 /

+ (+0.00%)

EADSY Airbus
$0.00 /

+ (+0.00%)

AER AerCap
$27.42 /

-1.39 (-4.82%)

Hot Stocks
Workhorse Group submits HorseFly delivery drone for FAA type certification » 08:12
10/28/20
10/28
08:12
10/28/20
08:12
WKHS

Workhorse Group

$17.22 /

-1.32 (-7.12%)

Workhorse Group has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WKHS Workhorse Group
$17.22 /

-1.32 (-7.12%)

WKHS Workhorse Group
$17.22 /

-1.32 (-7.12%)

10/26/20 Vertical Group
Workhorse Group initiated with a Sell at Vertical Group
10/13/20 Roth Capital
Workhorse downgraded at Roth after Postal Service delays contract award
10/13/20 Roth Capital
Workhorse Group downgraded to Neutral from Buy at Roth Capital
10/09/20 Roth Capital
Roth Capital sees positive outcome for Workhorse in USPS contract
WKHS Workhorse Group
$17.22 /

-1.32 (-7.12%)

WKHS Workhorse Group
$17.22 /

-1.32 (-7.12%)

WKHS Workhorse Group
$17.22 /

-1.32 (-7.12%)

WKHS Workhorse Group
$17.22 /

-1.32 (-7.12%)

Upgrade
ViewRay upgraded to Buy from Neutral at B. Riley Securities » 08:11
10/28/20
10/28
08:11
10/28/20
08:11
VRAY

ViewRay

$3.01 /

+0.01 (+0.33%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRAY ViewRay
$3.01 /

+0.01 (+0.33%)

VRAY ViewRay
$3.01 /

+0.01 (+0.33%)

10/07/20 Piper Sandler
ViewRay amended agreement with Siemens favorable, says Piper Sandler
06/23/20 Piper Sandler
Piper Sandler bullish on ViewRay as 1-year prostate data adds to data compendium
06/16/20 Cantor Fitzgerald
ViewRay assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
ViewRay assumed with an Overweight at Cantor Fitzgerald
VRAY ViewRay
$3.01 /

+0.01 (+0.33%)

  • 04
    Dec
Hot Stocks
Crispr to initiate Phase 1/2 trial of stem cell-derived therapy in 2021 » 08:11
10/28/20
10/28
08:11
10/28/20
08:11
CRSP

Crispr Therapeutics

$98.05 /

+3.94 (+4.19%)

CRISPR Therapeutics,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

10/22/20 RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/22/20 Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
10/22/20 Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
10/22/20 Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

Hot Stocks
Crispr Therapeutics expects to report data from Phase 1 trials of CTX130 in 2021 » 08:11
10/28/20
10/28
08:11
10/28/20
08:11
CRSP

Crispr Therapeutics

$98.05 /

+3.94 (+4.19%)

CRISPR Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

10/22/20 RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/22/20 Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
10/22/20 Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
10/22/20 Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

Hot Stocks
Crispr Therapeutics expects to report data from Phase 1 trial of CTX120 in 2021 » 08:10
10/28/20
10/28
08:10
10/28/20
08:10
CRSP

Crispr Therapeutics

$98.05 /

+3.94 (+4.19%)

CRISPR Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

10/22/20 RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/22/20 Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
10/22/20 Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
10/22/20 Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

Hot Stocks
Whirlpool Chief Legal Officer Kirsten Hewitt to retire, Ava Harter to succeed » 08:10
10/28/20
10/28
08:10
10/28/20
08:10
WHR

Whirlpool

$195.89 /

+1.885 (+0.97%)

, OC

Owens Corning

$68.92 /

-0.3 (-0.43%)

Whirlpool (WHR) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

OC Owens Corning
$68.92 /

-0.3 (-0.43%)

WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

10/23/20 JPMorgan
Whirlpool price target raised to $237 from $192 at JPMorgan
10/23/20 Deutsche Bank
Whirlpool price target raised to $199 from $153 at Deutsche Bank
10/23/20 RBC Capital
Whirlpool upgraded to Sector Perform from Underperform at RBC Capital
10/23/20 RBC Capital
Whirlpool upgraded to Sector Perform from Underperform at RBC Capital
OC Owens Corning
$68.92 /

-0.3 (-0.43%)

10/13/20 Benchmark
Benchmark upgrades Owens Corning to Buy, sees 'best set-up in several years'
10/13/20 Benchmark
Owens Corning upgraded to Buy from Hold at Benchmark
09/21/20 Jefferies
Owens Corning named Franchise Pick at Jefferies
09/04/20 Loop Capital
Owens Corning price target raised to $80 from $71 at Loop Capital
WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

OC Owens Corning
$68.92 /

-0.3 (-0.43%)

WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

OC Owens Corning
$68.92 /

-0.3 (-0.43%)

WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

Earnings
Hess Midstream Partners reports Q3 EPS 31c, consensus 35c » 08:10
10/28/20
10/28
08:10
10/28/20
08:10
HESM

Hess Midstream Partners

$17.76 /

+0.495 (+2.87%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HESM Hess Midstream Partners
$17.76 /

+0.495 (+2.87%)

HESM Hess Midstream Partners
$17.76 /

+0.495 (+2.87%)

10/16/20 Citi
Hess Midstream Partners upgraded to Buy from Neutral at Citi
10/15/20 Citi
Hess Midstream Partners upgraded to Buy from Neutral at Citi
10/05/20
Fly Intel: Top five analyst initiations
10/05/20 UBS
Hess Midstream Partners initiated with a Buy at UBS
HESM Hess Midstream Partners
$17.76 /

+0.495 (+2.87%)

Hot Stocks
Crispr Therapeutics to report additional data from Phase 1 CARBON trial in 2021 » 08:10
10/28/20
10/28
08:10
10/28/20
08:10
CRSP

Crispr Therapeutics

$98.05 /

+3.94 (+4.19%)

On October 21, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

10/22/20 RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/22/20 Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
10/22/20 Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
10/22/20 Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

Recommendations
Stanley Black & Decker price target raised to $179 from $163 at Credit Suisse » 08:10
10/28/20
10/28
08:10
10/28/20
08:10
SWK

Stanley Black & Decker

$166.44 /

-6.46 (-3.74%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWK Stanley Black & Decker
$166.44 /

-6.46 (-3.74%)

SWK Stanley Black & Decker
$166.44 /

-6.46 (-3.74%)

06:54 Today Deutsche Bank
Stanley Black & Decker price target raised to $200 from $192 at Deutsche Bank
09/23/20 Citi
Citi ups Stanley Black & Decker target, opens 'Positive Catalyst Watch'
09/14/20 UBS
Stanley Black & Decker price target raised to $184 from $173 at UBS
08/31/20 Baird
Stanley Black & Decker price target raised to $184 from $175 at Baird
SWK Stanley Black & Decker
$166.44 /

-6.46 (-3.74%)

SWK Stanley Black & Decker
$166.44 /

-6.46 (-3.74%)

Hot Stocks
Crispr expects to report data from patients treated with CTX001 in Q4 » 08:09
10/28/20
10/28
08:09
10/28/20
08:09
CRSP

Crispr Therapeutics

$98.05 /

+3.94 (+4.19%)

, VRTX

Vertex Pharmaceuticals

$212.23 /

+5.04 (+2.43%)

CRISPR Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

10/22/20 RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/22/20 Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
10/22/20 Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
10/22/20 Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

06:13 Today UBS
Vertex Pharmaceuticals initiated with a Buy at UBS
10/26/20 Stifel
SAP news impact may be company-specific for software sector, says Stifel
10/15/20 Truist
Vertex Pharmaceuticals price target lowered to $305 from $330 at Truist
10/15/20 Morgan Stanley
VX-814 discontinuation can drive Vertex shares 5%-10% lower, says Morgan Stanley
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

  • 01
    Jul
  • 21
    Nov
VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

Upgrade
Red Rock Resorts upgraded to Buy from Hold at Union Gaming » 08:09
10/28/20
10/28
08:09
10/28/20
08:09
RRR

Red Rock Resorts

/

+

Union Gaming analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RRR Red Rock Resorts
/

+

RRR Red Rock Resorts
/

+

07:09 Today Goldman Sachs
Red Rock Resorts price target raised to $26 from $20 at Goldman Sachs
06:51 Today Deutsche Bank
Red Rock Resorts price target raised to $24 from $22 at Deutsche Bank
10/14/20 JPMorgan
Red Rock Resorts price target raised to $23 from $21 at JPMorgan
09/14/20 Goldman Sachs
Red Rock Resorts price target raised to $20 from $15 at Goldman Sachs
RRR Red Rock Resorts
/

+

RRR Red Rock Resorts
/

+

RRR Red Rock Resorts
/

+

Initiation
Repare Therapeutics initiated with an Outperform at Northland » 08:09
10/28/20
10/28
08:09
10/28/20
08:09
RPTX

Repare Therapeutics

$26.32 /

-0.435 (-1.63%)

Northland analyst Tim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPTX Repare Therapeutics
$26.32 /

-0.435 (-1.63%)

RPTX Repare Therapeutics
$26.32 /

-0.435 (-1.63%)

09/25/20 Piper Sandler
Repare Therapeutics viewed as core long-term holding at Piper Sandler
07/14/20
Fly Intel: Top five analyst initiations
07/14/20 Morgan Stanley
Repare Therapeutics initiated with an Overweight at Morgan Stanley
07/14/20 Goldman Sachs
Repare Therapeutics initiated with a Neutral at Goldman Sachs
RPTX Repare Therapeutics
$26.32 /

-0.435 (-1.63%)

  • 19
    Jun
RPTX Repare Therapeutics
$26.32 /

-0.435 (-1.63%)

Hot Stocks
Titan Pharmaceuticals to acquire JT Pharma's JT/09 for chronic pruritus » 08:08
10/28/20
10/28
08:08
10/28/20
08:08
TTNP

Titan Pharmaceuticals

$0.13 /

-0.0209 (-14.04%)

Titan Pharmaceuticals has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TTNP Titan Pharmaceuticals
$0.13 /

-0.0209 (-14.04%)

TTNP Titan Pharmaceuticals
$0.13 /

-0.0209 (-14.04%)

08/17/20 Maxim
Titan Pharmaceuticals downgraded to Hold from Buy at Maxim
08/14/20 Maxim
Titan Pharmaceuticals downgraded to Hold from Buy at Maxim
TTNP Titan Pharmaceuticals
$0.13 /

-0.0209 (-14.04%)

Recommendations
Crocs price target raised to $60 from $45 at Monness Crespi » 08:08
10/28/20
10/28
08:08
10/28/20
08:08
CROX

Crocs

$54.80 /

+2.69 (+5.16%)

Monness Crespi analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CROX Crocs
$54.80 /

+2.69 (+5.16%)

CROX Crocs
$54.80 /

+2.69 (+5.16%)

08:01 Today Susquehanna
Crocs price target raised to $68 from $53 at Susquehanna
07:52 Today Baird
Crocs price target raised to $72 from $50 at Baird
07:21 Today Stifel
Crocs price target raised to $50 from $42 at Stifel
06:43 Today UBS
Crocs price target raised to $57 from $48 at UBS
CROX Crocs
$54.80 /

+2.69 (+5.16%)

  • 31
    Oct
CROX Crocs
$54.80 /

+2.69 (+5.16%)

CROX Crocs
$54.80 /

+2.69 (+5.16%)

CROX Crocs
$54.80 /

+2.69 (+5.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.